Data as of Dec 10
| -0.02 / -0.50%|
The 5 analysts offering 12-month price forecasts for Antares Pharma Inc have a median target of 6.50, with a high estimate of 6.50 and a low estimate of 6.00. The median estimate represents a +63.32% increase from the last price of 3.98.
The current consensus among 5 polled investment analysts is to Buy stock in Antares Pharma Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.